Determining the Relative Antihypertensive Potency and Relative Cardiovascular Risk Reduction Associated With Different Thiazide and Thiazide-Type Diuretics

Journal of Clinical Hypertension

Volumn 15, Issue 6, 2013, Pages 359-361

  Basile, Jan N ^a   Bloch, Michael J ^b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEVADA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BENDROFLUMETHIAZIDE; CHLOROTHIAZIDE; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROCHLOROTHIAZIDE; PLACEBO; POTASSIUM; THIAZIDE DIURETIC AGENT;

ANTIHYPERTENSIVE ACTIVITY; ARTICLE; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR RISK; CLINICAL PRACTICE; DIASTOLIC BLOOD PRESSURE; DOSE RESPONSE; DRUG MECHANISM; DRUG POTENCY; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; MONOTHERAPY; POTASSIUM BLOOD LEVEL; POTASSIUM DEPLETION; PRIMARY PREVENTION; PRIORITY JOURNAL; RESISTANT HYPERTENSION; RISK REDUCTION; TABLET;

BENDROFLUMETHIAZIDE; BLOOD PRESSURE; CHLORTHALIDONE; HUMANS; HYDROCHLOROTHIAZIDE; POTASSIUM; URIC ACID;

EID: 84878773818     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12079     Document Type: Article

References (0)